Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001437749-20-009936
Filing Date
2020-05-08
Accepted
2020-05-08 09:17:36
Documents
3
Effectiveness Date
2020-05-08

Document Format Files

Seq Description Document Type Size
1 FORM DEFA14A kmph20200505_defa14a.htm DEFA14A 17947
2 notice01.jpg GRAPHIC 281056
3 notice02.jpg GRAPHIC 238802
  Complete submission text file 0001437749-20-009936.txt   735006
Mailing Address 1180 CELEBRATION BOULEVARD, SUITE 103 CELEBRATION FL 34747
Business Address 1180 CELEBRATION BOULEVARD, SUITE 103 CELEBRATION FL 34747 (321) 939-3416
KEMPHARM, INC (Filer) CIK: 0001434647 (see all company filings)

EIN.: 205894398 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-36913 | Film No.: 20858980
SIC: 2834 Pharmaceutical Preparations